Retrospective analysis of health care resource utilization in patients (pts) with ipilimumab-refractory (IPI-R) melanoma covered in a large U.S. claims database.
2015 ◽
Vol 33
(15_suppl)
◽
pp. e20056-e20056
2015 ◽
Vol 33
(15_suppl)
◽
pp. e20028-e20028
2020 ◽
Vol 26
(10)
◽
pp. 1266-1275
2020 ◽
Vol 40
(6)
◽
pp. 599-599
2020 ◽
Vol 26
(12)
◽
pp. 1506-1516
2019 ◽
Vol 39
(10)
◽
pp. 983-993
◽